DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome
White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study
Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome
Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer’s disease except for the putamen
Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer’s disease in Down syndrome
